Results 171 to 180 of about 329,829 (287)

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Cognitive and affective processes in children's third-party punishment. [PDF]

Q J Exp Psychol (Hove)
Arini RL, Bocarejo Aljure J, Bueno Guerra N, Bayón González C, Fernández Alba E, Suárez Fernández N, Ingram GPD, Wiggs L, Kenward B.   +8 more
europepmc   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Evaluating the safety and feasibility of prophylactic third-party NK cell administration in high-risk AML patients post-HSCT. [PDF]

BMC Cancer
Barkhordar M, Tavoosi S, Tavakoli S, Salavatipour MS, Bahri T, Chahardouli B, Baghsheikhi AH, Vaezi M, Babakhani D, Rad S, Mousavi SA, Janbabai G, Salehi-Shadkami H, Ahmadvand M.   +13 more
europepmc   +1 more source

Enhancing gridded climate products with third party weather data in a rainfall study from Western Australia. [PDF]

Sci Rep
Li M, Shao Q.
europepmc   +1 more source

Safety concerns reported by coroners following fentanyl patch fatalities in England, Wales and Northern Ireland between 1997 and 2024

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim To identify safety concerns reported by coroners following fentanyl patch‐related deaths in England, Wales and Northern Ireland, and determine differences in coronial reporting. Methods A systematic case series linking the National Programme on Substance Use Mortality (NPSUM) and the Preventable Deaths Tracker (PDT) (https ...
Eman Mshari, Caroline S. Copeland, Georgia C. Richards   +2 more
wiley   +1 more source

Mandatory Third-Party Exclusion of Individuals with Gambling Problems in Germany: Data from the OASIS Player Exclusion System. [PDF]

J Gambl Stud
Meyer G.
europepmc   +1 more source

Third Party Contingency contracts in settlement and litigation

We present, for the first time, a model of recent institutional developments in litigation funding across several European jurisdictions. Recognizing the financing constraints that British cost rules may impose on litigants, these new contractual ...
Roland Kirstein, Neil Rickman
core  

Exploring new avenues: Psychedelic‐assisted therapy for young people

British Journal of Clinical Pharmacology, EarlyView.
Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou, Dasha Nicholls, David J. Nutt, Martina Di Simplicio   +3 more
wiley   +1 more source

Third-Party Resources: The New Wave of Medical Education. [PDF]

Med Sci Educ
Matsko C, Cervantes J.
europepmc   +1 more source